Amy Ewald

463 total citations
9 papers, 335 citations indexed

About

Amy Ewald is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Amy Ewald has authored 9 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Amy Ewald's work include Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Amy Ewald is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Amy Ewald collaborates with scholars based in United States, New Zealand and Israel. Amy Ewald's co-authors include Bronwyn M. Kivell, Thomas E. Prisinzano, David A. Young, Chad E. Groer, Andrew P. Riley, Bridget Simonson, Denise S. Simpson, Leigh C. Walker, Nitin Kumar and John H. Miller and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Molecules.

In The Last Decade

Amy Ewald

9 papers receiving 333 citations

Peers

Amy Ewald

CMN

MB

OC

PHYSI

PHARM

Anthony Lozama United States

Richard W. Zink United States

Prabhakar R. Polepally United States

D. Malcolm Duckworth United Kingdom

Irena Berezowska Canada

Rachel Saylor Crowley United States

Jill M. Wetter United States

Antonio Cilia Italy

Willy P. Burkard Switzerland

Vincent P. Rocco United States

Anthony Lozama United States

Amy Ewald

240 ×1.2

CMN

207 ×1.1

MB

78 ×1.0

OC

39 ×0.6

PHYSI

58 ×2.1

PHARM

Citations per year, relative to Amy Ewald Amy Ewald (= 1×) peers Anthony Lozama

Countries citing papers authored by Amy Ewald

Since Specialization

Citations

This map shows the geographic impact of Amy Ewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ewald more than expected).

Fields of papers citing papers by Amy Ewald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Ewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ewald. The network helps show where Amy Ewald may publish in the future.

Co-authorship network of co-authors of Amy Ewald

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Ewald. A scholar is included among the top collaborators of Amy Ewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Ewald. Amy Ewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Danzig, Carl J., David Eichenbaum, Amy Ewald, et al.. (2024). Screen Failures in Clinical Trials in Retina. Ophthalmology Retina. 8(11). 1093–1099. 1 indexed citations

2.

Ewald, Amy, et al.. (2023). The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules. 28(12). 4848–4848. 7 indexed citations

3.

Wang, Rui, Raziyeh Mahmoudzadeh, Mirataollah Salabati, et al.. (2022). Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmology. 7(1). e001188–e001188. 18 indexed citations

4.

Ewald, Amy, Peter Bösch, Rachel Saylor Crowley, et al.. (2017). The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects. Psychopharmacology. 234(16). 2499–2514. 26 indexed citations

5.

Riley, Andrew P., Chad E. Groer, David A. Young, et al.. (2014). Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues. Journal of Medicinal Chemistry. 57(24). 10464–10475. 91 indexed citations

6.

Kivell, Bronwyn M., Željko Uzelac, Jeyaganesh Rajamanickam, et al.. (2014). Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86. 228–240. 74 indexed citations

7.

Kivell, Bronwyn M., Amy Ewald, & Thomas E. Prisinzano. (2014). Salvinorin A Analogs and Other Kappa-Opioid Receptor Compounds as Treatments for Cocaine Abuse. Advances in pharmacology. 69. 481–511. 52 indexed citations

8.

Simonson, Bridget, Amy Ewald, Leigh C. Walker, et al.. (2014). Pharmacology and anti‐addiction effects of the novel κ opioid receptor agonistMesylSalB, a potent and long‐acting analogue of salvinorinA. British Journal of Pharmacology. 172(2). 515–531. 48 indexed citations

9.

Ewald, Amy, et al.. (2013). The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats. European Journal of Pharmacology. 720(1-3). 69–76. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact